What is the “synthesis date” for sugammadex?
“Sugammadex synthesis date” isn’t a standard public, regulatory field. In practice, people usually mean one of these:
1) the date the active pharmaceutical ingredient (API) was first synthesized/discovered,
2) the date a specific manufacturing process (or intermediate) was developed/patented,
3) the date sugammadex was first approved for use in a country/region, which is sometimes loosely treated as a “starting date” for production.
With only the phrase “sugammadex synthesis date” provided, there isn’t enough information to identify which of those meanings you want.
When was sugammadex first approved (and why that gets called a “date”)?
If what you mean is the earliest official approval date, that would be determined by the first regulator/market to approve sugammadex. Approval dates can differ by country, and they are not the same thing as synthesis or process-development dates.
Could you mean the date from a patent/manufacturing route?
Patent records often include:
- filing dates for the process or intermediates,
- priority dates,
- publication dates,
- sometimes references to when compounds were first prepared.
If you’re trying to find the “synthesis date” for sugammadex in the sense of the synthesis described in a patent, I can help—but I need at least one detail to locate the right record.
Tell me which date you want
Reply with one of these so I can answer precisely:
- the country/region (FDA/EMA/UK, etc.) and whether you mean approval date, or
- a patent number/publication (or applicant/company name), or
- the specific intermediate/process step you mean by “synthesis.”
Sources: none (the provided prompt didn’t include any factual claims or references to cite).